Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.02

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.02. Revenue for the quarter came in at $10.08 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• Citi sees tower stocks benefiting from potential Starlink network build
• HawkEye 360 lock-up ends early, shares eligible Sept. 2